WHO SAYS VACCINE MANUFACTURERS ARE ALSO ENCOURAGED TO PROVIDE SUCH DATA FOR ANY NOVEL, BROADLY REACTIVE SARS-COV-2 VACCINES THAT ARE DEVELOPED